Last Updated 1 December 2022.
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Non Replicating Viral Vector
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form